Fielmann Aktiengesellschaft (FLMNY)
USD 8.62
(0.0%)
USD 8.62
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.96 Billion EUR | 6.5% |
| 2022 | 1.84 Billion USD | -6.78% |
| 2021 | 1.98 Billion USD | 21.77% |
| 2020 | 1.62 Billion USD | -4.3% |
| 2019 | 1.7 Billion USD | 19.19% |
| 2018 | 1.42 Billion EUR | 3.03% |
| 2017 | 1.38 Billion EUR | 3.65% |
| 2016 | 1.33 Billion EUR | 2.86% |
| 2015 | 1.29 Billion EUR | 5.99% |
| 2014 | 1.22 Billion EUR | 6.0% |
| 2013 | 1.15 Billion EUR | 4.52% |
| 2012 | 1.1 Billion EUR | 5.09% |
| 2011 | 1.05 Billion EUR | 6.01% |
| 2010 | 993.69 Million EUR | 4.33% |
| 2009 | 952.49 Million EUR | 5.52% |
| 2008 | 902.67 Million EUR | 7.57% |
| 2007 | 839.18 Million EUR | 5.84% |
| 2006 | 792.91 Million EUR | 8.16% |
| 2005 | 733.07 Million EUR | 13.28% |
| 2004 | 647.14 Million EUR | -21.24% |
| 2003 | 821.69 Million EUR | 24.77% |
| 2002 | 658.58 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 529.11 Million EUR | 12.16% |
| 2024 Q2 | 552.69 Million EUR | 4.46% |
| 2023 Q4 | 471.74 Million EUR | -17.62% |
| 2023 Q1 | 512.54 Million USD | 13.66% |
| 2023 Q3 | 572.67 Million EUR | 6.69% |
| 2023 Q2 | 536.78 Million USD | 4.73% |
| 2023 FY | 1.96 Billion EUR | 6.5% |
| 2022 Q2 | 440.11 Million EUR | 6.2% |
| 2022 Q3 | 465.77 Million USD | 5.83% |
| 2022 Q4 | 450.94 Million USD | -3.18% |
| 2022 FY | 1.84 Billion USD | -6.78% |
| 2022 Q1 | 414.42 Million EUR | -3.11% |
| 2021 Q4 | 427.72 Million EUR | -7.18% |
| 2021 FY | 1.98 Billion USD | 21.77% |
| 2021 Q2 | 407.65 Million EUR | 6.72% |
| 2021 Q1 | 381.98 Million EUR | -3.81% |
| 2021 Q3 | 460.78 Million EUR | 13.03% |
| 2020 Q1 | 355.26 Million EUR | -68.3% |
| 2020 Q2 | 255.58 Million EUR | -28.06% |
| 2020 Q3 | 420.99 Million EUR | 64.72% |
| 2020 Q4 | 397.09 Million EUR | -5.68% |
| 2020 FY | 1.62 Billion USD | -4.3% |
| 2019 Q2 | 386.43 Million EUR | 3.95% |
| 2019 Q3 | 400.05 Million EUR | 3.52% |
| 2019 Q4 | 1.12 Billion EUR | 180.13% |
| 2019 Q1 | 371.75 Million EUR | 6.17% |
| 2019 FY | 1.7 Billion USD | 19.19% |
| 2018 Q4 | 350.17 Million EUR | -4.42% |
| 2018 Q1 | 349.85 Million EUR | 7.29% |
| 2018 Q3 | 366.35 Million EUR | 1.31% |
| 2018 FY | 1.42 Billion EUR | 3.03% |
| 2018 Q2 | 361.62 Million EUR | 3.37% |
| 2017 Q2 | 353.48 Million EUR | 3.4% |
| 2017 FY | 1.38 Billion EUR | 3.65% |
| 2017 Q4 | 326.07 Million EUR | -10.55% |
| 2017 Q3 | 364.54 Million EUR | 3.13% |
| 2017 Q1 | 341.87 Million EUR | 4.27% |
| 2016 Q4 | 327.85 Million EUR | -6.04% |
| 2016 FY | 1.33 Billion EUR | 2.86% |
| 2016 Q1 | 316.36 Million EUR | 0.98% |
| 2016 Q2 | 344 Million EUR | 8.74% |
| 2016 Q3 | 348.94 Million EUR | 1.44% |
| 2015 Q2 | 327.22 Million EUR | 3.19% |
| 2015 Q4 | 313.28 Million EUR | -8.48% |
| 2015 Q3 | 342.32 Million EUR | 4.61% |
| 2015 FY | 1.29 Billion EUR | 5.99% |
| 2015 Q1 | 317.1 Million EUR | 7.42% |
| 2014 Q4 | 295.19 Million EUR | -7.26% |
| 2014 Q1 | 306.34 Million EUR | 8.18% |
| 2014 FY | 1.22 Billion EUR | 6.0% |
| 2014 Q2 | 306.64 Million EUR | 0.1% |
| 2014 Q3 | 318.3 Million EUR | 3.8% |
| 2013 Q3 | 302 Million EUR | 2.69% |
| 2013 FY | 1.15 Billion EUR | 4.52% |
| 2013 Q1 | 277.8 Million EUR | 2.73% |
| 2013 Q2 | 294.1 Million EUR | 5.87% |
| 2013 Q4 | 283.18 Million EUR | -6.23% |
| 2012 Q1 | 271.49 Million EUR | 5.38% |
| 2012 Q4 | 270.43 Million EUR | -5.3% |
| 2012 Q3 | 285.55 Million EUR | 2.13% |
| 2012 Q2 | 279.59 Million EUR | 2.98% |
| 2012 FY | 1.1 Billion EUR | 5.09% |
| 2011 Q3 | 272.13 Million EUR | 1.63% |
| 2011 FY | 1.05 Billion EUR | 6.01% |
| 2011 Q1 | 255.88 Million EUR | 5.4% |
| 2011 Q2 | 267.77 Million EUR | 4.65% |
| 2011 Q4 | 257.63 Million EUR | -5.33% |
| 2010 FY | 993.69 Million EUR | 4.33% |
| 2010 Q3 | 260.29 Million EUR | 3.93% |
| 2010 Q1 | 241.66 Million EUR | 2.48% |
| 2010 Q2 | 250.45 Million EUR | 3.64% |
| 2010 Q4 | 242.77 Million EUR | -6.73% |
| 2009 Q1 | 226.33 Million EUR | 0.0% |
| 2009 Q4 | 235.82 Million EUR | -4.45% |
| 2009 Q3 | 246.79 Million EUR | 3.61% |
| 2009 Q2 | 238.18 Million EUR | 5.24% |
| 2009 FY | 952.49 Million EUR | 5.52% |
| 2008 FY | 902.67 Million EUR | 7.57% |
| 2007 FY | 839.18 Million EUR | 5.84% |
| 2006 FY | 792.91 Million EUR | 8.16% |
| 2005 FY | 733.07 Million EUR | 13.28% |
| 2004 FY | 647.14 Million EUR | -21.24% |
| 2003 FY | 821.69 Million EUR | 24.77% |
| 2002 FY | 658.58 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -61598.168% |
| Ansell Limited | 1.61 Billion USD | -21.601% |
| Ansell Limited | 1.61 Billion USD | -21.601% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -966.4% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1457884.525% |
| Psykey, Inc. | 419.29 Thousand USD | -469512.615% |
| ConvaTec Group Plc | 2.19 Billion USD | 10.252% |
| ConvaTec Group Plc | 2.14 Billion USD | 8.09% |
| Encision Inc. | 6.58 Million USD | -29798.516% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -107799.284% |
| LifePoint, Inc. | -18.5 Thousand USD | 10643781.081% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -28801.82% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -254962.306% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -199559.407% |
| Reflect Scientific, Inc. | 1.08 Million USD | -182196.321% |
| SmileDirectClub, Inc. | 470.74 Million USD | -318.292% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -5.208% |
| SheerVision, Inc. | 3.49 Million USD | -56168.991% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -141939.207% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -264173.185% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -1888109.008% |